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Programming of adipose tissue miR-483-3p and GDF-3
expression by maternal diet in type 2 diabetes
D Ferland-McCollough1,5, DS Fernandez-Twinn2,5, IG Cannell3, H David3, M Warner2, AA Vaag4, J Bork-Jensen4, C Brøns4, TW Gant1,
AE Willis*,1, K Siddle*,2, M Bushell*,1 and SE Ozanne*,2
Nutrition during early mammalian development permanently influences health of the adult, including increasing the risk of type 2
diabetes and coronary heart disease. However, the molecular mechanisms underlying such programming are poorly defined.
Here we demonstrate that programmed changes in miRNA expression link early-life nutrition to long-term health. Specifically, we
show that miR-483-3p is upregulated in adipose tissue from low-birth-weight adult humans and prediabetic adult rats exposed to
suboptimal nutrition in early life. We demonstrate that manipulation of miR-483-3p levels in vitro substantially modulates the
capacity of adipocytes to differentiate and store lipids. We show that some of these effects are mediated by translational
repression of growth/differentiation factor-3, a target of miR-483-3p. We propose that increased miR-483-3p expression in vivo,
programmed by early-life nutrition, limits storage of lipids in adipose tissue, causing lipotoxicity and insulin resistance and thus
increasing susceptibility to metabolic disease.
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Diet can have important health consequences at any stage of
life, but nutrition during fetal and early postnatal life is
particularly important as it has major implications for health
throughout the life course. The ‘developmental origins of
health and disease hypothesis’ proposes that early-life
exposure to environmental factors such as suboptimal
nutrition has permanent (‘programmed’) effects on the
structure and function of key tissues.1,2 These effects may
be beneficial in a situation of continuing nutrient deprivation
throughout life. However, they become detrimental in the face
of subsequent nutrient excess, making individuals more
vulnerable to the effects of an obesogenic diet and increasing
the risk of age-associated diseases, especially type 2
diabetes and the metabolic syndrome.
The molecular mechanisms by which nutrition during
critical periods of development permanently alters the
metabolic phenotype of an organism are poorly defined.2,3
We and others have addressed this issue using a rat model
of maternal protein restriction that exhibits phenotypic
similarities to low-birth-weight (LBW) humans, including
development of insulin resistance in muscle and adipose
tissue and age-dependent loss of glucose tolerance leading
to overt diabetes in late adulthood.4,5 Both adipose tissue
and skeletal muscle from nutritionally programmed rats
and LBW humans display changes in expression of key
insulin signalling proteins before development of insulin
resistance.6,7
Adipose tissue has been identified as playing a pivotal role
in linking early dietary manipulation to long-term metabolic
health.8 Some of the earliest effects and those of greatest
magnitude have been demonstrated in adipose tissue.4,6,7
Adipose tissue is known to play a central role in the regulation
of metabolic homeostasis through synthesis and storage of
lipids and secretion of adipokines that can modulate metabo-
lism in other tissues. In both rodents and humans, the limited
capacity to store lipid in adipose tissue and the consequential
ectopic deposition in tissues such as liver and skeletal muscle
leads to insulin resistance and metabolic disease.9 Therefore,
the ability to expand adipose tissue and the capacity to store
triglycerides is essential in maintaining optimal health.
Many nutritionally programmed changes in protein levels
occur in the absence of changes in the level of corresponding
mRNAs,7 indicating a post-transcriptional regulatory mechan-
ism. It is well established that miRNAs can regulate gene
expression by influencing mRNA translation without neces-
sarily changing mRNA levels.10,11 A growing number of
miRNAs have been implicated in the regulation of adipose
tissue glucose and lipid metabolism12,13 in adipogenesis14
and in diabetes.15,16 However, it remains to be investigated
whether miRNAs are susceptible to programming in adipose
tissue. Here we address the hypothesis that programmed
expression of key miRNAs in adipose tissue mediates effects
of early nutrition on adipose cell metabolism and consequently
on long-term health. We show that as a consequence of
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upregulation of miR-483-3p in both rats and humans, there is
dysregulated expression of one of its targets GDF3 (growth/
differentiation factor-3), leading to an inhibition of adipocyte
differentiation and maturation. We suggest that this could limit
the capacity of adipose tissue to store lipids, leading to ectopic
triglyceride deposition, insulin resistance and type 2 diabetes.
Results
Adipose tissue mass and adipocyte size are decreased
in low-protein rat offspring. The rat model of maternal
protein restriction shows striking phenotypic similarities to
LBW humans in terms of both physiology and cellular indices
of programming. It is therefore an ideal system to define the
molecular pathways linking early nutrition to long-term
metabolic health.7,17 Rat dams were fed a low-protein (LP)
diet (8% protein) or a control diet (20% protein) during
pregnancy and lactation. Both groups were weaned at 3
weeks onto a normal laboratory chow diet fed ad libitum. We
studied young adult postpubertal male offspring aged 3
months. At this age, levels of glucose, insulin, triglycerides
and cholesterol were not significantly different in LP offspring
and controls (Table 1a), although LP offspring become
hyperglycaemic in later life.18 Compared with controls, at 3
months, LP offspring had significantly reduced body weight
and reduced body fat, both in absolute terms and as a
percentage of body weight (Table 1a). Histology of white
adipose tissue shows that this decrease in adiposity is
because of the considerably smaller size of adipocytes of LP
rats compared with the controls (Figures 1a and b).
Expression of miRNA-483-3p in adipose tissue is
programmed by early-life nutrition. We analysed miRNA
expression in epididymal adipose tissue from LP rat offspring
using microarrays at 22 days and 3 months of age
(Figure 1c). Only one miRNA was found to be upregulated
at both ages miRNA-483-3p (Figures 1c–e), suggesting that
this is a sustained programmed event. Interestingly, this miR-
483-3p had not been implicated in type 2 diabetes previously
and had a number of predicted targets known to influence
adipose tissue biology. At 22 days and 3 months, there was a
2.0- and 2.3-fold upregulation of miR-483-3p in LP offspring,
respectively, as measured by RT-qPCR (Figures 1d and e).
Similar data were obtained by RNAse protection assays on
different tissue samples from those used to generate the
microarray data, and RT-qPCR on kidney, liver and skeletal
muscle did not show changes in miR-483-3p expression
(data not shown).
To establish the relevance of this observation to human
biology, we investigated levels of miR-483-3p in a well-
characterised cohort of young adult LBW men (for subject
characteristics, see Table 1b). This cohort has been used
previously to study the consequences and mechanisms of
programming resulting from poor fetal growth.19,20 We found a
twofold increase in miR-483-3p expression in adipose
biopsies from LBW men compared with controls (Figure 1f).
Similar expression of miR-483-3p in both rats and humans
suggests that modulation of miR-483-3p by poor fetal nutrition
is a conserved phenomenon.
Within the rat and human genomes the miR-483-3p
sequence lies within an intron of the Igf2 gene. RT-PCR
analysis of rat adipose tissue demonstrated expression
of IGF2 mRNA from promoters P2 and P3 but not P1
(Figure 1g). There was a small, but significant, increase in
expression from the P3 promoter in LP rat offspring
(Figure 1g); however, the magnitude of this difference was
much smaller than that observed for miR-483-3p. There
was no difference in expression from the P2 promoter. This
suggests that miR-483 expression can be independently
regulated from IGF2.
GDF3 is a potential target of miR-483-3p and is
downregulated in LP rat offspring and LBW men.
Examination of online databases (http://www.targetscan.
org/, http://www.microrna.org, http://www.ebi.ac.uk/enright-srv/
microcosm/) revealed a large number of potential miR-483-3p
targets. Candidates were selected for investigation based on
potential roles in adipocyte biology, including GDF3, which is
expressed at high levels in adult adipose tissue21,22 and is
one of several members of the BMP/TGF-b family to have
been implicated in regulation of adiposity and energy
expenditure as well as cell-fate determination.23,24 Western
blotting of rat adipose tissue revealed a 40% decrease
in expression of GDF3 protein (Figure 2a) but no decrease in
Table 1 Characteristics of (a) rats and (b) humans
Control LP
Mean S.E.M. Mean S.E.M.
(a) Low-protein and control rat offspring
Body weight (g) 519 11 416*** 8
Epidymal fat weight (g) 9.23 0.31 5.88*** 0.22
Epidymal fat (% BW) 1.78 0.06 1.41*** 0.05
Intraabdominal fat weight (g) 3.52 0.19 2.47*** 0.17
Intraabdominal fat (% BW) 0.68 0.04 0.59 0.04
Retroperitoneal fat weight (g) 11.10 0.58 7.14*** 0.40
Retroperitoneal fat (% BW) 2.14 0.11 1.72*** 0.10
Glucose (mmol/l) 5.2 0.1 4.8 0.1
Insulin (pmol/l) 96 14 63 12
Total cholesterol (mmol/l) 2.00 0.14 1.97 0.10
Triglycerides (mmol/l) 1.40 0.22 0.99 0.07
Free fatty acids (mmol/l) 1154 98 972 44
HDL (mmol/l) 0.85 0.06 0.86 0.04
LDL (mmol/l) 0.62 0.05 0.85 0.13
(b) Low-birth-weight and control humans
Age (years) 24.5 0.34 24.1 0.10
Wt (kg) 82.41 3.25 80.66 2.97
Ht (m) 1.86 0.03 1.77* 0.02
BMI (kg/m2) 23.93 0.87 25.88 1.14
FFM DXA (kg) 61.93 2.44 58.15 1.53
FFM DXA (%) 20.88 2.15 23.77 2.23
Glucose (mmol/l) 4.66 0.17 5.02 0.15
Insulin (pmol/l) 33.40 6.36 39.33 4.51
C-peptide (pmol/l) 432 64 513 39
TG (mmol/l) 1.01 0.14 1.16 0.13
FFA (mmol/l) 319.00 44 330 30
FPIR (pmol/l) 2147 485 1986 258
M-value clamp (mg/kg FFM/min) 13.24 0.57 14.06 1.07
GOX clamp (mg/kg FFM/min) 5.08 0.32 4.96 0.25
NOGM clamp (mg/kg FFM/min) 8.63 0.39 9.18 1.12
In (a), data are means and S.E.M. Significant differences between control and
low-protein (LP) offspring are indicated (***Po0.001). In (b), data are means
and S.E.M. Significant differences between control and low-birth-weight (LBW)
subjects are indicated (*Po0.05)
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expression of other predicted targets (data not shown). There
was no difference between levels of GDF3 mRNA
determined by RT-PCR in control and LP adipose tissue
(relative levels±S.E.M. 100±12 in controls and 101±9 in
LP, n¼ 8 animals per group), indicating that the effect of
maternal diet on GDF3 expression was exerted at a post-
transcriptional level. Analysis of protein expression of GDF3
in human adipose tissue revealed a substantial (70%)
decrease in GDF3 protein expression in LBW humans
compared with controls (Figure 2b). These results
demonstrate that the effect of suboptimal early nutrition
and growth on both miR-483-3p and GDF3 protein is
conserved between humans and rats.
miR-483-3p directly regulates GDF3 expression by
translational repression. The 30UTR of GDF3 mRNA
contains a predicted miR-483-3p target site corresponding
perfectly to nucleotides 2–8 of the mature miRNA. The seed
target sequence is conserved between mammals including
humans, rat and mouse (Figure 3a) but is not conserved in
chicken or Xenopus (data not shown). The miR-483-3p seed
target site in the human, rat and mouse GDF3 mRNA 30UTRs
is downstream of, but close to, the stop codon (Figure 3a).
These localisation features are consistent with previously
identified ‘hospitable sites’ for miRNA interaction.25
To examine the relationship between miR-483-3p and
GDF3, miR-483-3p mimic was expressed in HEK293 cells
Figure 1 Adipocyte size is reduced in fat pads of low-protein (LP) rat offspring whereas miR-483-3p expression is increased. (a) Histological images of WAT (bar
represents 100mm) showing reduced adipocyte size in LP offspring. (b) Cell sizes quantified as a frequency distribution±95% CI (n¼ 5 per group, ***Po0.001). (c) Venn
diagram of up- and down-regulated miRNA expression established by microarrays showing sustained miR-483-3p upregulation through rat maturation. (d) miR-483-3p
expression was determined by quantitative PCR in adipose tissue from 3-month-old offspring of LP and control (C) rat dams. miR-483-3p expression is increased twofold in the
LP group compared with the control (n¼ 4 per group). (e) miR-483-3p expression was determined by quantitative PCR in adipose tissue from 3-month-old offspring of LP and
control (C) rat dams. miR-483-3p expression is increased 2.3-fold in the LP group compared with the control (n¼ 7 per group). (f) miR-483-3p expression was determined by
quantitative PCR in adipose tissue from young adult men of low birth weight (LBW) or normal birth weight (NBW). The LBW group exhibit a twofold increase in miR-483-3p
expression compared with the NBW group (n¼ 10 per group). (g) Promoter-specific expression of IGF2 mRNA was determined by quantitative PCR in adipose tissue from
3-month-old offspring of LP and control (C) rat dams. IGF-2 mRNA expression is under the control of promoters 2 and 3 in adipose tissue. IGF2 mRNA expression dependant
on promoter 3 is increased 1.25-fold in the LP group. (n¼ 8 per group all from different litters). *Po0.05, ***Po0.001
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that have low levels of endogenous miR-483-3p. Transfection
of miR-483-3p mimic significantly decreased the level of
GDF3 endogenous protein (Figure 3b), demonstrating that
GDF3 expression is regulated by miR-483-3p.
To establish whether there is a direct interaction between
GDF3 and miR-483-3p in the RNA-induced silencing complex
(RISC), immunoprecipitation (IP) of the Ago2 protein (a central
component of the RISC) was carried out. HepG2 cells
that express high endogenous levels of miR-483-3p were
used and the Ago2 IP was carried out in the presence or
absence of miR-483-3p antagonist. The total RNA from the
Ago2 IP was isolated and RT-qPCR carried out to quantify the
levels of miR-483-3p and GDF3 mRNA present. Importantly, it
was demonstrated that both miR-483-3p and GDF3 mRNA
were associated with Ago2 (Figure 3c). Whereas miR-483-3p
association with Ago2 was not changed significantly in the
presence of an antagonist, GDF3 mRNA association with
Ago2 was completely abrogated by a miR-483-3p antagonist
(Figure 3c). These results demonstrate that both miR-483-3p
and GDF3 mRNA associate with the RISC and that the
binding of GDF3 mRNA is dependent on miR-483-3p.
To confirm that the predicted seed sequence for miR-483-
3p is mediating the repressive effect on GDF3 translation, the
30UTR of human, rat and mouse GDF3 cDNAs encompassing
the predicted site were cloned into a luciferase-based reporter
plasmid. The constructs were transfected into HEK293 cells,
together with increasing concentrations of a miR-483-3p
mimic. Luciferase activity was decreased significantly in the
presence of the mimic in all species (Figure 3d). The
specificity of this effect was shown by introducing point
mutations within the miR-483-3p target seed sequence of the
rat 30UTR that made it insensitive to the presence of miR-483-
3p (Figure 3d). In addition, transfection of an antagonist to
miR-483-3p in HepG2 cells relieved the repression of the
luciferase reporter under the control of the 30UTR from the
GDF3 transcript (Figure 3e).
Taken together, these data confirm the presence of a
functional and direct miR-483-3p target site in the 30UTRs of
the mouse, rat and human GDF3 mRNA.
miR-483-3p regulates adipocyte differentiation and lipid
accumulation. Having established a relationship between
miR-483-3p and GDF3, it was then important to investigate
the expression patterns of these two components during the
adipocyte differentiation process using the murine 3T3-L1
cell line. Consistent with our observations that miR-483-3p
directly regulates GDF3, we demonstrated that during
adipocyte differentiation, the expression of miR-483-3p was
inversely correlated with that of GDF3. The expression of
miR-483-3p decreased gradually to 50% of its original levels
by day 9 of differentiation (Figure 4ai). In contrast, GDF3
mRNA and protein expression increased significantly during
this period (Figure 4aii and iii). GDF3 protein was virtually
undetectable in undifferentiated cells (day 0) and after 4 days
of differentiation, but was highly expressed after 7 and 9 days
of differentiation, suggesting that it does not play a role in
early stages of the differentiation process. It is important to
note that although GDF3 mRNA increased approximately
twofold during differentiation, the protein expression showed
an eightfold increase (Figure 4aiii), consistent with post-
transcriptional regulation.
To define the role of miR-483-3p in adipocyte differentiation
and lipid accumulation, the effect of modulating miR-483-3p was
investigated in the 3T3-L1 cell line. Expression of miR-483-3p
mimic substantially inhibited adipocyte differentiation as defined
by expression of FABP4 and PPARg2 mRNAs. The expression
of these mRNAs was dramatically reduced throughout the
differentiation process in the presence of the miR-483-3p mimic
(90% decrease for both markers at day 9) and, importantly,
significantly increased in the presence of miR-483-3p
antagonist (two- and three-fold increase at day 9 for PPARg2
and FABP4, respectively; Figure 4b). Immunohistochemical
Figure 2 Adipose tissue expression of GDF3 protein is decreased in
low-protein (LP) rat offspring and low-birth-weight (LBW) humans. (a) GDF3
protein expression was determined by western blotting in adipose tissue from
3-month-old offspring of LP and control (C) rat dams. GDF3 protein expression is
decreased by 30% in the LP group (n¼ 8 per group). (b) GDF3 protein expression
was determined by western blotting in adipose tissue from young adult men of
LBW or normal birth weight (NBW). A 70% decrease in GDF3 protein expression
is observed in the LBW group compared with the NBW group (n¼ 7 per group).
*Po0.05, **Po0.01
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studies (Figure 4ci) showed that transfection of miR-483-3p
mimic decreased the number of FABP4-positive cells by 50%
while decreasing the number of lipid droplet-containing cells
by 80% (Figure 4c) on day 9 of differentiation. Sequestration
of miR-483-3p by the use of the antagonist had the opposite
effect and increased the amount of FABP4-positive and lipid
droplet-containing cells twofold (Figure 4c).
Given the effects of miR-483-3p on GDF3 expression and
that GDF3 is one of several members of the BMP family to
have been implicated in the regulation of adipocyte size and
expandability,21,23 the influence of GDF3 on differentiation
and lipid accumulation was examined in vitro. Specific
targeting of GDF3 mRNA using siRNA resulted in decreased
induction of FABP4 and PPARg mRNAs on days 7 and 9 of
differentiation (Figure 5a), with no significant effect at earlier
time points, consistent with the absence of GDF3 at earlier
stages of differentiation (Figure 4aiii). Knockdown of GDF3
also decreased the number of FABP4-positive cells and
Figure 3 GDF3 protein expression is controlled by miR-483-3p. (a) Sequence alignment of miR-483-3p and human, mouse, dog, bovine and rat GDF3 mRNA 30UTR. The
miR-483-3p seed and target sequences are highlighted. (b) HEK293 cells were transfected with a mimic of miR-483-3p. GDF3 protein expression was evaluated by western
immunoblotting. (c) HepG2 cells expressing high levels of miR-483-3p were transfected with a miR-483-3p 20-O-Methyl antagonist. Ago2 protein immunoprecipitation was
performed and total RNA was collected. RT-qPCR was performed to assay the levels of miR-483-3p and GDF3 mRNA levels present in the immunoprecipitated RISC
complex. (d) HEK293 cells were co-transfected with luciferase reporter constructs containing a portion of the 30UTR of GDF3 mRNA spanning the miR-483 seed target region
(human, mouse, rat wild-type or rat with mutated seed sequence (Rat mut)), together with 0, 10 or 50 nM miR-483-3p mimic. (e) HepG2 cells were co-transfected with
luciferase reporter constructs containing a portion of the 30UTR of rat GDF3 mRNA spanning the miR-483 seed target region, together with 0 or 100 nM miR-483-3p
20-O-Methyl miR antagonist. Data are mean of 4–8 independent experiments. *Po0.05, **Po0.01, ***Po0.001 versus mimic or antagonist
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reduced the number of lipid-containing cells by 70% on day 9
of differentiation (Figure 5b).
Taken together, these data strongly suggest that miR-483-
3p represses the expression of GDF3 that is required for lipid
accumulation at the late stages of differentiation.
Discussion
It is well established that suboptimal early growth and nutrition
is associated with increased risk of diseases such as type 2
diabetes in later life. However, the molecular mechanisms by
which events during critical periods of development perma-
nently alter the physiology and metabolism of an organism,
following multiple rounds of cell division, are poorly defined.
We, and others, have demonstrated previously that pro-
grammed changes in DNA methylation and histone modifica-
tions affecting transcription of ‘gatekeeper genes’, such as
transcription factors, contribute to this cellular memory.26,27
However, there is strong evidence to suggest that post-
transcriptional mechanisms also play a critical role in
nutritional programming. The data presented herein demon-
strate that sustained programmed changes in miRNA
permanently influence gene expression and tissue physiol-
ogy, providing a novel post-transcriptional mechanism by
which early environmental factors control long-term metabolic
health.
Programming the expression of key miRNAs (each with
multiple targets) provides a mechanism by which coordinated
Figure 4 miR-483-3p modulates adipocyte differentiation. (a) Levels of miR-483-3p (i) and GDF3 mRNA (ii) were measured by RT-qPCR from differentiating 3T3-L1 pre-
adipocytes whereas protein level of GDF3 was assayed by western immunoblotting (iii). (b) 3T3-L1 cells were transfected with miR-483-3p mimic or 20-O-Methyl miR-483-3p
antagonist and expression of FABP4 (i) and PPARg2 (ii) was determined by quantitative PCR after 0, 4, 7 and 9 days (d) of differentiation. (c) 3T3-L1 cells were transfected
with miR-483-3p mimic or 20-O-Methyl miR-483-3p antagonist. On day 9 of differentiation, cells were stained with Hoechst reagent (blue) or labelled anti-FABP4 antibody (red)
(i). For each experimental condition, panels show the same field of view for both staining reagents. Histograms represent percentage of cells marked with FABP4 (ii) or
percentage of cells containing lipid droplets (iii) relative to stained nuclei. Data are mean of 3–5 independent experiments. *Po0.05, **Po0.01, ***Po0.001 versus
scrambled control
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regulation of gene networks can be achieved through central
nodes of regulation. Our observation that the changes in
miRNA expression in both rats and humans occur before the
development of the metabolic phenotype suggests that they
are causative and do not arise as a consequence of metabolic
dysfunction. This also raises the possibility that they could be
used as markers of disease risk if such changes were
identified in a clinically accessible tissue. Our study identified
a number of miRNAs that were differentially expressed in
adult rat offspring as a result of alterations in maternal diet,
and we focused on miR-483-3p as it was the only maintained
programmed change that occurred at 22 days and 3 months
and it has not previously been implicated in the development
of type 2 diabetes or regulation of metabolic health. Our data
suggest that programming of miR-483-3p is fundamentally
important as levels of miR-483-3p were increased in adipose
tissue from LP rat offspring and in LBW humans, showing that
programming of miR-483-3p was therefore conserved
between species. Modulation of miR-483-3p levels in vitro
revealed that this miRNA regulates early and late stages of
differentiation as well as the capacity of adipocytes to store
lipids. Therefore, dysregulation of miR-483-3p expression
could have a substantial impact on whole body physiology by
directly inhibiting adipose tissue expandability and lipid
storage, which would in turn affect other tissues by promoting
ectopic triglyceride storage and lipotoxicity. Consistent with
this hypothesis, development of diabetes in the LP rat model is
not associated with increased adiposity, and although older
animals exhibit increased hepatic lipid accumulation,28 they
do not become obese.4 It is also well documented that LBW
humans are at increased risk of nonalcoholic fatty liver
disease.29 We therefore suggest that upregulation of miR-
483-3p in adipose tissue of rat LP offspring and LBW men
contributes to the metabolic imbalance leading to diabetes by
limiting their capacity for triacylglyceride storage in adipocytes
and therefore enhancing ectopic lipid accumulation in other
tissues including muscle and liver. By limiting adipose tissue
expandability, increased expression of miR-483-3p would
make such programmed individuals very vulnerable to the
detrimental effects of an obesogenic diet.
The mechanisms that link programmed changes in expres-
sion of miRNAs, each with multiple potential targets, to
metabolic phenotype and disease susceptibility are likely to be
exceedingly complex. Our bioinformatics and experimental
approach identified GDF3 as a target that mediates the effects
of miR-483-3p on adipose tissue. We showed that levels of
GDF3 protein were reduced in adipose tissue from both LP rat
offspring and LBW humans, and that manipulation of GDF3
expression influenced the later stages of differentiation and
lipid accumulation in 3T3-L1 cells. However, GDF3 protein
was almost undetectable in undifferentiated 3T3-L1 cells and
during the first few days of differentiation, and therefore the
effects of miR-483-3p on the early stages of differentiation are
likely to be mediated through other as yet unidentified targets.
Consistent with our observations that the reduction in GDF3
in LP offspring is accompanied by a decrease in adipose cell
size, it has been shown previously that compared with wild-
type animals, GDF3-deficient mice have anB40% decrease
in adipocyte size when fed a normal chow diet and exhibit an
obesity-resistant phenotype when fed a high-fat diet.21,22 In
adipocytes, GDF3 appears to signal through an ALK7/Cripto
receptor complex, and ALK7-deficient mice also demon-
strated decreased expansion of fat cell mass and smaller cell
size when fed a high-fat diet.21 Moreover, mice overexpres-
sing GDF3 exhibited increased weight gain on a high-fat diet
compared with control animals and this was accompanied by
increased adipocyte size.30 GDF3 is expressed in both
mature adipocytes and stromal/vascular cells,22 and therefore
it might act in either a paracrine or autocrine manner.
The mechanisms through which the programmed increase
in miR-483-3p arises are currently unknown. miR-483 is an
intragenic miRNA, located in intron 2 of the Igf2 gene,31 which
is paternally imprinted.32 Altered methylation of the locus has
been linked to programmed changes in expression of IGF2 in
an ovine model of periconceptual undernutrition;33 however,
this study in sheep did not assess the levels of miR-483.
Although we observed increased expression of IGF2 mRNA
from one of the Igf2 gene promoters (P3) in adipose tissue of
LP offspring, the magnitude of the change in IGF2 mRNA was
much less than that of miR-483-3p, and expression of IGF2
transcripts from the other main promoter were not different.
Independent regulation of IGF2 and miR-483 in adult tissues
would be expected given that IGF2 transcript levels in adult
Figure 5 GDF3 modulates adipocyte differentiation. (a) 3T3-L1 cells were
transfected with siRNA targeting GDF3, and expression of FABP4 (i) and PPARg2
(ii) was determined by quantitative PCR after 0, 4, 7 and 9 days (d) of differentiation.
(b) 3T3-L1 cells were transfected with siRNA targeting GDF3. On day 9 of
differentiation, cells were stained with Hoechst reagent (blue) or labelled anti-
FABP4 antibody (red) (i). Histograms represent percentage of cells marked with
FABP4 (ii) or percentage of cells containing lipid droplets (iii) relative to stained
nuclei. Data are mean of 3–5 independent experiments. *Po0.05, **Po0.01,
***Po0.001 versus scrambled control
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rats are very low.34 Expression of mouse miR-483* was
reported to be downregulated, whereas IGF2 was upregu-
lated in the liver of offspring of dams fed a high-fat diet during
pregnancy and lactation,33 and a recent study showed that
expression of miR-483-3p can be induced independently of
IGF2 by b-catenin and promoter-region methylation in vitro.35
Indeed, it is well established that miRNA expression can be
regulated independently from the host gene either through the
use of an alternative promoter, differential processing or
through modulation of transcript stability.36
In conclusion, we propose that by modulating adipose
tissue expandability and thus the ability of the individual to
store lipids within adipose tissue, programmed changes in
miRNAs contribute to the relationship between early-life
nutrition and long-term health. These findings not only
contribute to our understanding of fundamental biological
processes, but also have important implications for improving
human health as programmed miRNAs represent potential
markers of disease risk as well as providing targets of rational
therapeutic intervention strategies.
Materials and Methods
Animals. The LP rat model has been described in detail previously.37 Virgin
female Wistar rats weighing 240–260 g were housed individually and maintained at
221C on a 12 h light–dark cycle. They were mated and day 1 of gestation was taken
as the day on which vaginal plugs were expelled. The pregnant dams were then
randomised into two dietary groups, control and LP, fed ad libitum and weighed
daily. The control group received a 200 g protein/kg diet and the LP group received
an isoenergetic 80 g protein/kg diet, as described.38 Dams were maintained on their
respective experimental diets throughout pregnancy and lactation. At 48 h after
delivery, litters were reduced at random to 8 pups with an equal gender ratio where
possible. At 21 days of age, all pups were weaned onto standard chow (LAD1 diet,
Special Diets Services, Witham, UK) and fed ad libitum. The animals were then
maintained on this diet throughout the study. At 22 days and 3 months of age, a
single male offspring from each litter was fasted overnight, and the next day blood
was taken for glucose measurements (OneTouch Ultra, LifeScan Inc., Milpitas, CA,
USA) and serum was obtained for determination of fasting insulin (Ultrasensitive
mouse insulin EIA kit, Mercodia, Uppsala, Sweden) and lipid analysis (Mouse
Biochemistry Laboratory, Department of Clinical Biochemistry, Cambridge
University Hospitals NHS Foundation Trust, Cambridge, UK) (Table 1). The rats
were then killed by CO2 asphyxiation. Total body weights were recorded and
individual fat depots were collected and weighed and then either snap-frozen in
liquid nitrogen and stored for miRNA, mRNA and western analysis or fixed for
histological analysis. In all cases, ‘n’ refers to the different numbers of litters
represented in the analysis. All studies were approved by the Local Ethics
Committee and were conducted according to the Home Office Animals (Scientific
Procedures, UK) Act 1986.
Human subjects. A total of 20 human male volunteers born in Copenhagen
County between 1979 and 1980 after 39–41 weeks of gestation were recruited from
The Danish National Birth Registry according to birth weight. All subjects
participated in a recently published study.39 In all, 10 men had birth weights below
the 10th percentile for gestational age (LBW) and 10 men had birth weights in the
upper normal range (50th–90th percentile) (Control). The LBW subjects had a
slightly lower adult height but otherwise there were no significant differences
between groups in clamp insulin action (80 mU/m2/min insulin infusion, 3 h),
in vivo insulin secretion or DXA scan body composition (Table 1b). None of the
subjects had a family history of diabetes (parents or grandparents) or received
medication known to affect glucose or lipid metabolism. Subjects with BMI430 kg/
m2 were excluded. Lifestyle factors such as tobacco use, exercise and diet were not
different between groups, as assessed by an interview at inclusion. Subcutaneous
fat biopsies were obtained from the abdomen in the fasting basal state before the
clamp during local anaesthesia using a modified Bergstrom needle. Biopsies were
blotted free of blood, frozen immediately in liquid nitrogen and stored for later
analysis at 801C. The study protocol was reviewed and approved by
the regional ethical committee and procedures were performed according to the
principles of the Helsinki declaration. Written informed consent was obtained from
all participants.
Microarray analysis. Microarray slides were prepared in the laboratory of
Dr. Tim Gant based on the microRNA database found on miRBase v9.6 (http://
www.mirbase.org/). FlashTag 3DNA array detection kit (Genisphere, Hatfield, PA,
USA) was used to label 1 mg of total RNA (Oyster-550) and 10 ng of MirExplore
microRNA universal reference (Oyster-650, Miltenyi Biotec, Cologne, Germany).
Arrays were scanned using an Axon4200 scanner and data were compiled using
GenePix Pro 6.0 software (Molecular Devices, Sunnyvale, CA, USA). Analyses
were carried out on control and LP adipose tissue samples (four per group). These
samples were obtained from a separate cohort of animals to those used in validation
studies.
Immunoblotting. Adipose tissue (250 mg) was powdered on dry ice and
homogenized in 300ml lysis buffer (50 mM HEPES (pH 8), 150 mM NaCl, 1% Triton
X-100, 1 mM Na3VO4, 30 mM NaF, 10 mM Na4P2O7, 10 mM EDTA with protease
inhibitors (set III, Calbiochem Novabiochem Biosciences, Cambridge, UK)). Total
protein concentration of lysates was determined by a copper/bicinchoninic assay
(Sigma Aldrich, Poole, UK). Total protein (20 mg) from each sample (each animal
and each litter represented by one sample; n¼ 8 Controls, n¼ 8 LP) was subjected
to SDS-PAGE along with protein markers (Fermentas, York, UK). Separated
proteins were transferred onto PVDF membrane (Immobilon-P, Millipore, Billerica,
MA, USA). Protein blots were incubated in blocking buffer before incubation with
primary antibody according to the manufacturers’ protocols. Primary antibodies
used were against rat GDF3 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or
human GDF3 (Abcam, Cambridge, UK). This was followed by incubation with
horseradish peroxidase-linked secondary antibodies (Jackson ImmunoResearch,
West Grove, PA, USA) and detection by chemiluminescence (SuperSignal West
Pico, Pierce, UK). Autoradiographs were analysed by spot-densitometry
(AlphaEase, AlphaInnotech, San Leandro, CA, USA). Signals from 20 and 10mg
of a pooled sample confirmed linearity of exposure.
qRT-PCR analysis. RNA from rat and human adipose tissue was isolated
using the mirVana miRNA isolation kit (Ambion, Austin, TX, USA) whereas RNA
from cultured cells was isolated using the Trizol reagent protocol (Invitrogen,
Paisley, UK). The extracted RNA was purified by phenol–chloroform phase
extraction and re-precipitated using isopropanol. Isolated RNA was DNAse treated
and further purified using RNAeasy columns (Qiagen, Crawley, UK). For mRNA
expression analysis, cDNA synthesis was primed using random hexamers
(Promega, Southampton, UK). Specific primers for quantification were designed
using the Universal Probe Library Assay Design Center (Roche, Welwyn Garden
City, UK) and target specificity confirmed with Primer-blast (NCBI). qRT-PCR was
performed using the Sybr green master mix on the 7500 Fast Real Time PCR
system (Applied Biosystems, Warrington, UK). Expression was normalised to that of
the housekeeping genes cyclophilin and b-actin, which did not differ between
experimental groups. RT-qPCR of microRNAs was performed using TaqMan
MicroRNA assay kits for hsa-miR-483-3p, rno miR-483 and snU6 rRNA (Applied
Biosystems) according to the manufacturer’s protocol.
Primer list:
IGF2 (total) sense sequence: 50-CGCTTCAGTTTGTCTGTTCG-30
antisense sequence: 50-GCAGCACTCTTCCACGATG-30
IGF2 (P1) sense sequence: 50-TTGCCACACAGTTTTCCCATTT-30
antisense sequence: 50-TCCCAAATCAGACCCTTGTC-30
IGF2 (P2) sense sequence: 50-CAAGTGGATTAATTATACGCTTTCTG-30
antisense sequence: 50-AGAGGCGGGTAGGCTCAC-30
IGF2 (P3) sense sequence: 50-TGAGAACCTTCCAGCCTTTTCCTGTC-30
antisense sequence: 50-CTGAAGTTATAAGGATAAGGAFFCCGCT-30
GDF3 sense sequence: 50-ACACACAGAAACCTTCCCAAG-30
antisense sequence: 50-TTCTTTGACGGCAGACAAGTT-30
FABP4 sense sequence: 50-CCCTCCTGTGCTGCAGCCTT-30
antisense sequence: 50-TGGCCATGCCTGCCACTTTCC-30
PPARg2 sense sequence: 50-GCCTTCGCTGATGCACTGCC-30
antisense sequence: 50-TGCGAGTGGTCTTCCATCACGG-30
Cyclophilin sense sequence: 50-CCCCATCTGCTCGCAATA-30
antisense sequence: 50-TTTGCAATCCTGCTAGACTTGA-30
b-Actin sense sequence: 50-CGACAACGGCTCCGGCATGT-30
antisense sequence: 50-TCACACCCTGGTGCCTAGGGC-30
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Luciferase reporter constructs and assay. Luciferase reporter
constructs40 were generated by cloning the 30UTR portion of human, mouse and
rat GDF3 mRNA containing the seed target sequence of miR-483-3p that is highly
conserved across species (Figure 3a). PCR of HEK293 cDNA library using specific
primers yielded 181 of 199 bp of human 30UTR, PCR of mouse embryonic stem cell
cDNA yielded the first 200 of 900 bp of mouse 30UTR whereas PCR on rat white
adipose tissue cDNA yielded 200 of 724 bp of rat 30UTR. These PCR products were
then subcloned downstream of the luciferase gene contained in the pGL3-Basic
commercial vector (Promega). Mutation of the seed target sequence of the rat
GDF3 30UTR from AGGAGTG to AGGATAG was performed using the Quickchange
site-directed mutagenesis kit (Agilent Technologies, Edinburgh, UK).
HEK293 cells were used for miR-483-3p expression studies, and HepG2 cells for
miR-483-3p knockdown studies, because of their low and high levels of endogenous
miR-483-3p, respectively. Cells were transfected with 100 ng of reporter construct,
50 ng of p-b-Gal-control (Clontech, Basinstoke, UK) used as transfection control
and increasing concentrations of miR-483-3p mimic (0, 10 and 50 nM in HEK293) or
miR-483-3p 20-O-Methyl antagonist (0 and 100 nM in HepG2) using the transfection
reagent RNAi Max (Invitrogen). Cells were harvested and Luciferase assay was
performed using LAR-I substrate (Promega). A b-Galactosidase Tropix lumines-
cence (Applied Biosystems) assay was performed as a transfection efficiency control.
Luminescence was detected using the GloMax system (Promega).
Ago IPs. HepG2 were transfected with 100 nM of miR-483-3p 20-O-Methyl
antagonist or a scrambled 20-O-Methyl RNA sequence. The cells were then
harvested in PBS and then put in the presence of 1% formaldehyde for 1 h to
establish protein–RNA reversible crosslinking. Cells were lysed and sonicated. The
protein lysate was immunoprecipitated using a specific Ago2 mouse monoclonal
antibody (Abcam) and bound by A/G agarose beads (Santa Cruz Biotechnology).
Beads bound to the antibody were resuspended in water after precipitation and
heated at 751C for 45 min to disrupt RNA–protein bounds. RNA was then extracted
and purified using Trizol protocol.
3T3-L1 culture, differentiation and treatment. Monolayer cultures
of 3T3-L1 mouse preadipocytes were grown to confluence in DMEM supple-
mented with 10% newborn bovine serum. Cells were then treated with DMEM
supplemented with 10% fetal bovine serum (FBS), IBMX (0.5 mM), dexa-
methasone (1mM) and insulin (5 mg/ml) for 48 h. Medium was then removed
and replaced with DMEM containing 10% FBS and insulin (5mg/ml). After 48 h,
medium was removed and replaced with 10% FBS DMEM and changed
subsequently every 48 h.
Cells were transfected with 20 nM miR-483-3p mimic, 50 nM miR-483-3p
20-O-Methyl antagonist or 20 nM siRNA targeting GDF3 using RNAi max as a
transfectant (Invitrogen) 24 h before first treatment and again 24 h before second
treatment. Cells were harvested at days 0, 4, 7 and 9 of the differentiation protocol.
Immunohistochemistry of 3T3-L1 cells. After 9 days of differentiation
3T3-L1 cells were fixed on coverslips using 4% paraformaldehyde and
permeabilised using 0.1% Triton X-100. FABP4 protein was stained using a
specific monoclonal antibody (Cell Signaling Technology/NEB, Hitchin, UK) and a
secondary anti-mouse antibody conjugated with Alexa-488 fluorophore. The nuclei
were stained with Hoechst reagent.
Adipocyte cell size and number analysis. Adipose tissue was obtained
from epididymal fat pads of 3-month-old male Control and LP rat offspring (n¼ 5 per
group). The samples were fixed in paraformaldehyde, embedded in paraffin, cut into
5mm sections and stained with haematoxylin and eosin. Histological images (bar
represents 100mm) were digitally captured and individual cross-sectional areas of
adipocytes measured and quantified using Cell:D imaging analysis software
(Olympus, Southend-on-Sea, UK). Cell sizes were then presented as frequency
distribution histogram (mm2) and cell number per field at  4 magnification. Data
are then presented as means (95% CI); ***Po0.001 by two-tailed t-test.
Statistics. Data were analysed by unpaired Student’s t-tests using Prism 5
(GraphPad, La Jolla, CA, USA). For all the parameters studied in rodents,
‘n’ refers to the number of litters, from each of which one animal was taken. For all
data sets, Po0.05 was considered statistically significant. Human mir-483-3p
expression data were not normally distributed, and were log transformed before
analysis.
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